HNL Lab Medicine Executive and Leadership Team

Matthew Sorrentino, the Chief Executive Officer at HNL Lab Medicine, directs the overarching strategic vision and operational framework for the organization. Sorrentino guides the company's expansion and service delivery across Pennsylvania and New Jersey, ensuring alignment with market demands and healthcare provider needs. This leadership role involves fostering innovation in diagnostic testing and maintaining the highest standards of clinical and anatomic pathology services. By focusing on sustainable growth and operational efficiency, Matthew Sorrentino drives the company's mission to provide comprehensive laboratory solutions to physician offices, hospitals, long-term care facilities, employers, and industrial clients. The Chief Executive Officer's purview encompasses all facets of the business, from financial health to patient care outcomes, solidifying HNL Lab Medicine's position as a leading diagnostic provider.

David Beckwith, the President & Chief Executive Officer at HNL Lab Medicine, spearheads the organization's strategic direction and executive leadership. Beckwith oversees all critical business functions, ensuring HNL Lab Medicine effectively serves its diverse client base, including physician offices, hospitals, and industrial clients throughout Pennsylvania and New Jersey. This executive position involves driving operational excellence and championing the company's commitment to delivering extensive clinical and anatomic pathology results. David Beckwith's leadership focuses on enhancing service offerings and expanding the organization's reach, reinforcing its reputation for comprehensive laboratory services and its support for a wide array of medical and organizational requirements across the region.

Martin Till, the President & Chief Executive Officer at HNL Lab Medicine, commands the strategic vision and operational execution for the enterprise. Till directs the company's comprehensive laboratory services, ensuring the delivery of extensive clinical and anatomic pathology results to a broad spectrum of clients across Pennsylvania and New Jersey. This leadership role involves cultivating strong relationships with physician offices, hospitals, long-term care facilities, employers, and industrial clients. Martin Till's focus remains on driving innovation in diagnostic testing and maintaining the highest standards of quality and efficiency. By overseeing all aspects of the business, Till ensures HNL Lab Medicine continues its trajectory as a leading provider, supporting critical medical and organizational needs throughout the region.

David Confalone, the Chief Financial Officer at HNL Lab Medicine, oversees all financial operations, strategic planning, and fiscal management for the organization. Confalone directs the financial health of HNL Lab Medicine, ensuring robust resource allocation to support its extensive laboratory services across Pennsylvania and New Jersey. This executive position involves managing budgets, financial reporting, and investment strategies to sustain the company's growth and operational capabilities. David Confalone's responsibilities include optimizing financial performance and ensuring compliance with all regulatory requirements, thereby supporting the delivery of comprehensive clinical and anatomic pathology results. The Chief Financial Officer's expertise is vital in maintaining the organization's stability and its capacity to serve physician offices, hospitals, employers, and industrial clients effectively.

Warren Erdmann, the Chief Operating Officer at HNL Lab Medicine, directs the day-to-day operational activities and service delivery across the organization's extensive network. Erdmann oversees the efficient functioning of laboratory processes, ensuring the timely and accurate production of clinical and anatomic pathology results for clients throughout Pennsylvania and New Jersey. This critical role involves managing laboratory logistics, optimizing workflows, and implementing best practices to maintain high standards of quality and compliance. Warren Erdmann's leadership ensures that HNL Lab Medicine effectively supports physician offices, hospitals, long-term care facilities, employers, and industrial clients with comprehensive diagnostic services. The Chief Operating Officer's focus on operational excellence is fundamental to the company's mission and its ability to meet diverse medical and organizational demands.

Jessica Bargilione, the Chief Marketing Officer at HNL Lab Medicine, architects and executes the organization's comprehensive marketing and brand strategy. Bargilione drives market penetration and client engagement across Pennsylvania and New Jersey, focusing on communicating the value of HNL Lab Medicine's extensive clinical and anatomic pathology services. This role involves developing targeted campaigns for physician offices, hospitals, employers, and industrial clients, highlighting the organization's commitment to diagnostic excellence. Jessica Bargilione oversees market research, digital presence, and strategic communications, ensuring HNL Lab Medicine remains a recognized leader in providing comprehensive laboratory solutions. The Chief Marketing Officer's efforts directly support the company's growth objectives and its mission to serve a wide range of medical and organizational needs.

Jordan Olson, the Chief Medical Officer at HNL Lab Medicine, provides critical medical and scientific leadership, guiding the organization's diagnostic services and clinical integrity. Olson oversees the quality and accuracy of extensive clinical and anatomic pathology results, ensuring adherence to the highest medical standards across Pennsylvania and New Jersey. This role involves collaborating with laboratory professionals and healthcare providers to advance diagnostic capabilities and patient care. Jordan Olson's expertise is instrumental in interpreting complex medical data and ensuring that HNL Lab Medicine's services meet the evolving needs of physician offices, hospitals, and other healthcare partners. The Chief Medical Officer's commitment to medical excellence underpins the company's reputation for delivering comprehensive and reliable laboratory solutions.

Angela Connell, the Chief Administrative Officer at HNL Lab Medicine, directs the comprehensive administrative functions and operational support systems for the organization. Connell oversees human resources, legal affairs, and facility management, ensuring seamless operations across HNL Lab Medicine's locations in Pennsylvania and New Jersey. This leadership position is crucial for maintaining organizational efficiency and supporting the delivery of extensive clinical and anatomic pathology services. Angela Connell's responsibilities include developing and implementing policies that foster a productive work environment and ensure compliance with all relevant regulations. The Chief Administrative Officer's strategic oversight enables HNL Lab Medicine to effectively serve its diverse client base, including physician offices, hospitals, employers, and industrial clients, reinforcing its role as a leading diagnostic provider.